CollPlant Biotechnologies (CLGN) Inventory (2017 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Inventory came in at $573000.0 in Q4 2025, down 99.87% YoY from $440.0 million in Q4 2024, and up 3.62% on a QoQ basis from $553000.0 in Q2 2025.
CollPlant Biotechnologies (CLGN) Inventory (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 9 years of Inventory data on file, last reported at $573000.0 in Q4 2025.
- Quarterly Inventory fell 99.87% year-over-year to $573000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $573000.0 (down 99.87% YoY) and the FY2025 annual result came in at $573000.0, down 99.87% from the prior year.
- Inventory rose to $573000.0 in Q4 2025, from $553000.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $1081.0 billion in Q4 2021 to a low of $439000.0 in Q2 2024.
- A 5-year average of $60.4 billion and a median of $1.5 million in 2022 frame the typical range for Inventory.
- Annual changes were most pronounced in 2021 — Inventory soared 85657586.21% — and 2023, when it tumbled 99.95%.
- Tracing CLGN's Inventory over 5 years: stood at $1081.0 billion in 2021, then tumbled by 99.87% to $1.4 billion in 2022, then plunged by 99.95% to $714000.0 in 2023, then surged by 61524.65% to $440.0 million in 2024, then tumbled by 99.87% to $573000.0 in 2025.
- The last three Inventory figures came in at $573000.0 (Q4 2025), $553000.0 (Q2 2025), and $440.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 573,000.00 |
| Jun 30, 2025 | 553,000.00 |
| Dec 31, 2024 | 440.00 Mn |
| Sep 30, 2024 | 454.00 Mn |
| Jun 30, 2024 | 439,000.00 |
| Mar 31, 2024 | 645.00 Mn |
| Dec 31, 2023 | 714,000.00 |
| Sep 30, 2023 | 1.50 Bn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.78 Mn |
| Dec 31, 2022 | 1.43 Bn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 1.36 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1,081.00 Bn |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 940,000.00 |
| Mar 31, 2021 | 1.28 Bn |
| Dec 31, 2020 | 1.26 Mn |
| Sep 30, 2020 | 967,000.00 |